CDCP1 and central nervous system cancer: To further confirm these results, we examined the CDCP1 expression level in glioma tissues (grade II, n = 35; grade III, n = 42; and grade IV, n = 55) (Additional file 1: Table S10) and normal brain tissues (n = 35) by immunohistochemistry (Fig. 2A, B).